These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 8043236

  • 1. Four different regimens for prevention of Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.
    Tocchetti A, Tambini R, Allegro A, Longoni E, Rinaldi E.
    AIDS; 1994 Feb; 8(2):272-4. PubMed ID: 8043236
    [No Abstract] [Full Text] [Related]

  • 2. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group.
    Girard PM, Landman R, Gaudebout C, Olivares R, Saimot AG, Jelazko P, Gaudebout C, Certain A, Boué F, Bouvet E.
    N Engl J Med; 1993 May 27; 328(21):1514-20. PubMed ID: 8479488
    [Abstract] [Full Text] [Related]

  • 3. Once-weekly administration of dapsone/pyrimethamine vs. aerosolized pentamidine as combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patients.
    Opravil M, Hirschel B, Lazzarin A, Heald A, Pechère M, Rüttimann S, Iten A, von Overbeck J, Oertle D, Praz G.
    Clin Infect Dis; 1995 Mar 27; 20(3):531-41. PubMed ID: 7756472
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV.
    Podzamczer D, Salazar A, Jiménez J, Consiglio E, Santín M, Casanova A, Rufí G, Gudiol F.
    Ann Intern Med; 1995 May 15; 122(10):755-61. PubMed ID: 7717598
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Randomized trial of dapsone and aerosolized pentamidine for the prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.
    Torres RA, Barr M, Thorn M, Gregory G, Kiely S, Chanin E, Carlo C, Martin M, Thornton J.
    Am J Med; 1993 Dec 15; 95(6):573-83. PubMed ID: 8018144
    [Abstract] [Full Text] [Related]

  • 8. Failure of intravenous pentamidine prophylaxis for Pneumocystis carinii pneumonia.
    Weintrub PS, Wara DW, Duliege AM.
    J Pediatr; 1993 Jan 15; 122(1):163-4. PubMed ID: 8419606
    [No Abstract] [Full Text] [Related]

  • 9. Risks and benefits of aerosolized pentamidine and cotrimoxazole in primary prophylaxis of Pneumocystis carinii pneumonia in HIV-1-infected patients: a two-year Italian multicentric randomized controlled trial. The Italian PCP Study Group.
    Rizzardi GP, Lazzarin A, Musicco M, Frigerio D, Maillard M, Lucchini M, Moroni M.
    J Infect; 1996 Mar 15; 32(2):123-31. PubMed ID: 8708369
    [Abstract] [Full Text] [Related]

  • 10. Trimethoprim-sulfamethoxazole versus aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia: a prospective, randomized, controlled clinical trial. LFPMI Study Group. Ligue Française de Prévention des Maladies Infectieuses.
    May T, Beuscart C, Reynes J, Marchou B, Leclercq P, Borsa Lebas F, Saba J, Micoud M, Mouton Y, Canton P.
    J Acquir Immune Defic Syndr (1988); 1994 May 15; 7(5):457-62. PubMed ID: 8158539
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Thrice-weekly cotrimoxazole is better than weekly dapsone-pyrimethamine for the primary prevention of Pneumocystis carinii pneumonia in HIV-infected patients.
    Podzamczer D, Santín M, Jimenez J, Casanova A, Bolao F, Gudiol GR.
    AIDS; 1993 Apr 15; 7(4):501-6. PubMed ID: 8507417
    [Abstract] [Full Text] [Related]

  • 13. Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.
    Antinori A, Murri R, Ammassari A, De Luca A, Linzalone A, Cingolani A, Damiano F, Maiuro G, Vecchiet J, Scoppettuolo G.
    AIDS; 1995 Dec 15; 9(12):1343-50. PubMed ID: 8605054
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group.
    Bozzette SA, Finkelstein DM, Spector SA, Frame P, Powderly WG, He W, Phillips L, Craven D, van der Horst C, Feinberg J.
    N Engl J Med; 1995 Mar 16; 332(11):693-9. PubMed ID: 7854375
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Low-dose co-trimoxazole, aerosolised pentamidine, or dapsone plus pyrimethamine for prevention of Pneumocystis carinii pneumonia.
    Mallolas J, Zamora L, Gatell JM, Miró JM, Soriano E.
    Lancet; 1991 May 11; 337(8750):1162-3. PubMed ID: 1674036
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia.
    Warnock AC, Rimland D.
    Pharmacotherapy; 1996 May 11; 16(6):1030-8. PubMed ID: 8947975
    [Abstract] [Full Text] [Related]

  • 19. [The impact of the prevention of cerebral toxoplasmosis].
    Katlama C.
    J Neuroradiol; 1995 Sep 11; 22(3):193-5. PubMed ID: 7472536
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.